LICENSE AGREEMENT

                               LICENSE AGREEMENT

       LICENSE   AGREEMENT   ("the   Agreement"),   dated December ___, 2006, by and
among   Dr.   David P. Summers, an individual residing   at   3158   Canterbury   Ln.,
Montgomery, TX   77354   ("Summers"),   T.W.   Owen, an individual residing at 10635
Lessona   St.,   Las   Vegas,   NV 89141 ("Owen," and   together   with   Summers,   the
"Licensor"), and Datastand Technologies,   Inc., an Indiana corporation having an
office   at   8333   Weston   Road,   Suite 106, Woodbridge,   Ontario   L4L   8E2   (the
"Licensee").

                                   RECITALS:

       WHEREAS, Licensor is the inventor of certain technologies relating to the
use of fungi, plants, or animals for   the   production   of   anti-inflammatory and
analgesic   products   used to treat and cure inflammatory diseases,   and   is   the
owner of the entire right,   title   and   interest in and to certain Patent Rights
(defined below) relating to such technologies;  

       WHEREAS,      Licensor desires to have   the   Patent   Rights   developed and
commercialized and is willing to grant a license thereunder; and

       WHEREAS,      Licensee desires to obtain a license under the Patent Rights
upon the terms and conditions hereinafter set forth.

       NOW   THEREFORE,   in   consideration of the mutual covenants and agreements
herein, and other good and valuable consideration, the adequacy, sufficiency and
receipt of which are hereby acknowledged, the parties hereto agree as follows:

                                   ARTICLE I
                                  Definitions

       1.1    Definitions.   As   used in this Agreement, the following terms shall
have the following meanings:

       (a)    "Improvement" means   any   improvement, addition, or modification of
an invention claimed in the Patent Rights and shall include, without limitation,
any patentable invention that is (i) not   included in the Patent Rights and (ii)
is dominated by one or more Valid Claims of the Patent Rights.

       (b)    "Licensed Product" means any product   or   part   thereof,   that: (i)
absent the license granted hereunder, would infringe one or more Valid Claims of
the Patent Rights; or (ii) is manufactured by using a Licensed Process or   that,
when used, practices a Licensed Process.

       (c)    "Licensed   Process"   means   any   process   that,   absent the license
granted hereunder, would infringe one or more Valid Claims of the   Patent Rights
or which uses a Licensed Product.






                                       1


<PAGE>
       (d)    "Patent Rights" means:

             (i)     the United States provisional patent applications   listed on
Exhibit A attached hereto;

             (ii)    any   patent   applications   resulting   from   the   provisional
applications    listed    on    Exhibit   A,   and   any   divisionals,   continuations,
continuation-in-part applications,   and   continued prosecution applications (and
their relevant international equivalents) of the provisional patent applications
listed   on   Exhibit   A   and of such patent applications   that   result   from   the
provisional applications listed on Exhibit A, and the resulting patents;

             (iii)   any patents   resulting   from   reissues,   re-examinations, or
extensions   (and   their   relevant   international   equivalents)   of   the   patents
described in clauses (i) and (ii) of this subsection 1.1(d); and

             (iv)    international   (non-United   States) patent applications   and
provisional   applications   filed   after   the   date   hereof    and    the   relevant
international   equivalents   to   divisionals, continuations, continuation-in-part
applications and continued prosecution   applications   of the patent applications
to the extent the claims are directed to subject matter   specifically   described
in the patents or patent applications referred to in clauses (i), (ii) and (iii)
of this subsection 1.1(d), and the resulting patents.

       (e)    "Term"   shall mean the term of this Agreement, which shall commence
on
the date hereof and shall   remain   in effect until the expiration or abandonment
of   the   last remaining Valid Claim of   any   issued   patents   and   filed   patent
applications   within   the Patent Rights, unless earlier terminated in accordance
with the provisions of   this   Agreement,   in which case the Term shall terminate
upon the effective date of such termination.

       (f)    "Territory" means the following:   North   America   to include Mexico
and Canada (the "Territory").

       (g)    "Valid Claim" means either (i) a claim of an issued   patent   within
the Patent Rights that has not been held invalid by an administrative agency   or
court   of   competent   jurisdiction in any unappealed or unappealable decision or
(ii) a claim of a pending   application   that   has   not been abandoned or finally
rejected without the possibility of appeal or refilling.   The   invalidity   of   a
particular claim in one or more countries shall not invalidate such claim in the
remaining countries of the Territory.

                                   ARTICLE II
                                 License Grant

       2.1    License   Grant.   Subject   to   the   terms   and   conditions   of   this
Agreement,   Licensor   hereby grants to Licensee, and Licensee hereby accepts, an
exclusive, irrevocable,   perpetual   license   ("License")   in   the   Territory   to
develop and have developed,





                                       2


<PAGE>
to make and have made, to use and have used, to sell and have sold, and to lease
and have leased Licensed Products and Licensed Processes.  

       2.2    Exclusivity.    Licensor   agrees that it shall not retain any rights
to, and shall not directly or indirectly   grant   any other licenses to, develop,
make,   use, sell, and lease Licensed Products in the   Territory   or   to   perform
Licensed Processes in the Territory during the Term.

        2.3    Exclusive Option to Improvements.  

             (a)     Licensor   hereby   grants   to Licensee an exclusive option to
add Improvements to the Patent Rights.   Licensee   may exercise its option to add
such   Improvement   to   the   Patent   Rights by providing   Licensor   with   written
notification of Licensee's desire to   so   add   the   Improvement   to   the   Patent
Rights.   Upon Licensee's exercise of such right, such Improvement shall be added
to   the   Patent Rights and Exhibit A hereto shall be deemed to have been amended
to add the   invention   disclosure (and any related patent applications) covering
such Improvement.   Licensor shall not offer a license to such Improvement to any
third party.

             (b)     At Licensee's   option,   Licensor   shall   assign to Licensee,
without further consideration, its entire right, title and interest   in   and   to
each and every such Improvement.  

       2.4    Sublicenses.   Licensee shall have the right to grant sublicenses of
its rights under Section 2.1.

        2.5    Right   of   First   Refusal.    Licensee shall have the Right of First
Refusal   in   the   sale of any additional Territorial   Licenses   for   the   Patent
Rights, together with sixty (60) days to consummate such transaction.


                                   ARTICLE III
                                 CONSIDERATION

       3.1    Consideration.    In   consideration   of   the License, Licensee shall
issue to Licensor an aggregate of two million (2,000,000)   shares   of its common
stock (the "Consideration Shares") as follows:

Upon   execution of this Agreement, Licensee shall issue to Licensor two   million
(2,000,000) shares of the common stock of Licensee, which is hereby acknowledged
and agreed   to   constitute   consideration   for   the   grant of the License in the
Territory;


The Consideration Shares shall be allocated among each   Licensor   in   the manner
specified on Exhibit B attached hereto.  
      





                                       3


<PAGE>
                                   ARTICLE IV
                         Representations and Warranties

       4.1    Licensor's Representations and Warranties.   Each Licensor,   jointly
and severally, hereby warrants and represents to Licensee that:

       (a)    Authority.   This Agreement constitutes the legal, valid and binding
obligation of each Licensor, enforceable against each of them in accordance with
its   terms.   Upon the execution and delivery by each Licensor of this Agreement,
this Agreement   will   constitute the legal, valid and binding obligation of each
Licensor, enforceable against   each   of   them in accordance with its terms. Each
Licensor has the absolute and unrestricted right, power and authority to execute
and deliver this Agreement and to perform   its obligations under this Agreement,
and   such   action   has been duly authorized by   all   necessary   action   of   each
Licensor.

       (b)    Infringement;    No    Conflict;   Litigation.    No   patent   or   other
intellectual   property   right of any   third   party   is   infringed   or   has   been
challenged or threatened   in   any   way   by the Patent Rights or the technologies
relating to the Patent Rights.   To Licensor's   knowledge,   there is no patent or
patent application of any third party that may potentially infringe or otherwise
interfere with the Patent Rights.   Neither the execution and   delivery   of   this
Agreement   nor   the   consummation   or   performance   of   any   of the transactions
contemplated hereunder will, directly or indirectly (with or without   notice   or
lapse   of   time),   breach or give any governmental authority or other person the
right to challenge this   Agreement   or   any   of   the   transactions   contemplated
hereunder.    Licensor   has   not granted any other licenses with respect   to   the
Patent Rights.   Licensor is not   aware   of any existing or threatened litigation
concerning the Patent Rights.

       (c)    No Consent Required.   Licensor   is   not required to give any notice
to or obtain any consent from any person in connection   with   the   execution and
delivery   of   this   Agreement or the consummation or performance of any   of   the
transactions contemplated hereunder.

       (d)    Inventors;   Ownership.    Licensor   is   the   sole   inventor   of   the
technologies   relating to the Patent Rights.   Licensor is the sole and exclusive
owner of the entire   right, title and interest in and to the Patent Rights, free
and clear of all liens   or   other   encumbrances.   Licensor has full legal right,
authority to grant the exclusive License to Licensee as set forth herein.  

       (f)     Securities Matters.

             (i)     Licensor acknowledges its understanding that the issuance of
the Consideration Shares hereunder is   intended   to   be exempt from registration
under   the   Securities   Act   of   1933,   as amended (the "Securities   Act").    In
furtherance thereof, each of Licensor hereby   jointly   and   severally represents
and warrants to the Licensee that it is an "accredited investor" as that term is
defined   in Rule 501 of the General Rules and Regulations under   the   Securities
Act.   Licensor is acquiring the Consideration Shares for





                                       4


<PAGE>
its own account as principal, not as a nominee or agent, for investment purposes
only, and   not with a view to, or for, resale, distribution or fractionalization
thereof in whole   or   in   part   and   no   other   person   has a direct or indirect
beneficial interest in such shares or any portion thereof.    Each   Licensor   has
the   financial   ability   to   bear   the   economic   risk   of its investment.   Each
Licensor has such knowledge and experience in financial and   business matters as
to   be capable of evaluating the merits and risks of the prospective   investment
in the   shares being issued to it hereunder.   Each Licensor has been provided an
opportunity   for   a reasonable period of time prior to the date hereof to obtain
additional information   concerning the issuance of the shares, Licensee, and all
other information to the   extent   Licensee   possesses   such   information   or can
acquire it without unreasonable effort or expense.
      
             (ii)    Licensor understands that the Consideration Shares will   not
be   registered   under   the   Securities   Act   or the securities laws of any state
thereof, nor is such registration contemplated.   Licensor understands and agrees
further   that   such shares must be held and may not   be   transferred   until   and
unless the shares   are   registered   under   the Securities Act and the securities
laws   of   any other jurisdiction or an exemption   from   registration   under   the
Securities   Act   and any applicable laws is available. Licensor understands that
legends stating that   the   shares   have not been registered under the Securities
Act   and   the   securities laws of any other   jurisdiction   and   setting   out   or
referring to the   restrictions   on   the transferability and resale of the shares
will be placed on all documents evidencing the shares.

       (g)    Full Disclosure. No representation   or warranty of Licensor in this
Agreement   omits   to   state a material fact necessary   to   make   the   statements
herein, in light of the   circumstances   in which they were made, not misleading.
There is no fact known to Licensor that has   specific   application to the Patent
Rights and that materially adversely affects or, as far   as   can   be   reasonably
foreseen, materially threatens the Patent Rights that has not been set   forth in
this Agreement.

       4.2    Licensee's Representations and Warranties.  

       (a)    Authority.   This Agreement constitutes the legal, valid and binding
obligation   of   Licensee,   enforceable   against   Licensee in accordance with its
terms.   Upon   the execution and delivery by Licensee   of   this   Agreement,   this
Agreement will   constitute   the legal, valid and binding obligation of Licensee,
enforceable against Licensee   in   accordance   with   its   terms. Licensee has the
absolute and unrestricted right, power and authority to execute and deliver this
Agreement and to perform its obligations under this Agreement,   and   such action
has been duly authorized by all necessary action of Licensee.

       (b)    Issuance   of Consideration Shares.   The Consideration Shares,   when
issued   in   accordance   with    the    terms   hereof   and   on   the   basis   of   the
representations and warranties of set   forth   herein   and   paid   for   as   herein
provided, shall be duly and validly issued, fully paid, and non-assessable.






                                       5


<PAGE>
                                   ARTICLE V
                               Patent Prosecution

       5.1    Responsibility   for   Patent   Rights.   Licensor shall prepare, file,
prosecute, and maintain all of the Patent Rights.    Licensor   and   its appointed
patent   attorneys   shall   use reasonable efforts to copy Licensee on all   patent
correspondence as follows:   (a)   documents received from any patent office shall
be provided to Licensee promptly after   receipt; (b) any document to be filed in
any patent office shall be provided in draft form to Licensee sufficiently prior
to such document's filing to allow for review   and   comment by Licensee; an